Hangzhou Kang Sheng Health Management Consulting Co., a Chinese firm offering diabetes management equipment, has completed a US$100 million series C financing round, totaling from a series C1 and C2 round, according to a today’s statement.
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Read 2 Articles for Free with a Basic Account
Gain limited and restricted access to China Money Network.
Register Basic AccountSubscribe for an annual subscription!
Enjoy comprehensive and exclusive data you can't find elsewhere!
More Info
Already have an account or paid subscription? Log in
